Checkmate Pharmaceuticals
Latest round
- Series C
Last raised
- Jun 2020
Total raised
- $144M
Investors
- 11
About Checkmate Pharmaceuticals
Checkmate Pharmaceuticals, Inc.Founded in 2015 and headquartered in Cambridge, US, Checkmate Pharmaceuticals, Inc. specializes in immuno-oncology. The company has undergone significant strategic development, including its acquisition by Regeneron Pharmaceuticals, Inc. in May 2022, with the deal valuing Checkmate at approximately USD 250 million.0 million shares at USD 15 per share.Checkmate Pharmaceuticals, Inc. develops innovative therapies focused on enhancing the immune system's ability to fight cancer, particularly through its proprietary technology and platform for immuno-oncology.In 2021, Checkmate Pharmaceuticals, Inc.Checkmate Pharmaceuticals, Inc. The company is focused on launching new immuno-oncology therapies and aims to penetrate additional markets in North America and Europe by 2025., Checkmate is positioned to enhance its research capabilities and accelerate the pace of innovation in cancer treatment.
Who invested in Checkmate Pharmaceuticals
11 investors across 4 rounds
See all investors in Checkmate Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Checkmate Pharmaceuticals
Who invested in Checkmate Pharmaceuticals?
Checkmate Pharmaceuticals has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Checkmate Pharmaceuticals raised?
Checkmate Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Checkmate Pharmaceuticals last raise money?
Checkmate Pharmaceuticals's most recent round on record is a Series C, in Jun 2020.
What does Checkmate Pharmaceuticals do?
Checkmate Pharmaceuticals, Inc.
Where is Checkmate Pharmaceuticals headquartered?
Checkmate Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Checkmate Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Checkmate Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Checkmate Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.